Abstract: Several 1 receptor ligands with sub-nanomolar affinity and excellent selectivity have been reported, but relatively few 2 -selective ligands are known. 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl] piperazine (PB28; 1) has been reported by us as a high-affinity 2 receptor ligand with significant 2 selectivity, and several analogs of (1) now have been developed. Among these are the class of cyclohexylpiperazines that display a good compromise between affinity/activity and selectivity for 2 receptors. Very little is currently known about the nature of 2 receptors. In the absence of structure-based receptor information, we applied a comparative molecular field analysis (CoMFA) -a three-dimensional structure-activity relationship (3D-QSAR) method -to a set of cyclohexylpiperazine 2 ligands to develop a predictive model that might provide information about the stereoelectronic nature of the receptor binding site. Two CoMFA models were generated from two different alignments: the first used an automated FlexS algorithm, and the second used a rationally-driven manual alignment. Significantly better predictivity was obtained with the manual alignment (TSET: q 2 = 0.73, r 2 = 0.95; PSET: r 2 = 0.55/0.73) than from the automated alignment (TSET: q 2 = 0.69, r 2 = 0.98; PSET: r 2 = 0.13/0.16). The resulting CoMFA maps account for observed structure-affinity relationships and suggest a possible anatomy for the 2 receptor/cyclohexylpiperazine binding site.
INTRODUCTION
Modulation of the two sigma ( ) receptors, namely 1 and 2 , is showing important therapeutic potential (see editorial for this issue), and interest in sigma subtype research is growing. Several 1 receptor ligands with subnanomolar affinity and excellent selectivity toward the 1 receptor subtype have been developed [1, 2] . In contrast, relatively few 2 -selective ligands have been reported [3] , making it difficult to fully appreciate the pharmacology of the two subpopulations. In fact, although there are many compounds with subnanomolar affinity for the 2 receptor, their affinity for the 1 subtype is still very high. In an effort to better define the structural features required for ligand binding at receptor subtypes, several different series of compounds have been developed [4] [5] [6] [7] [8] [9] [10] [11] [12] . Many ligands possess either a piperidine or piperazine moiety embedded in their structure [1] [2] [3] . In a tetrahydronaphthalene series of compounds (see Table 1 for general structures), piperidine analogs displayed high affinity and selectivity for 1 receptors whereas the piperazine imparted moderate selectivity for the 2 receptor subtype [4, 8, 10] . Hence, attention was focused on piperazino-tetrahydronaphthalenes as potential 2 -selective ligands. Subsequent investigations examined the alkyl/aryl substituents on the N1 nitrogen atom of the piperazine ring (i.e., the N-atom not connected to the tetralin moiety; see Table 1 ).
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The results identified cyclohexylpiperazine derivatives as high-affinity compounds for 2 receptors with moderate selectivity. 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28; 1) displayed high affinity (K i = 0.34 nM) and 40-fold selectivity for 2 receptors [12] . Thus, PB28 (1) was selected as a lead compound and structural modification ensued [5, 12] . It was shown that the presence of the methoxy substituent was not necessary to obtain high affinity for 2 receptors; nevertheless the presence of the methoxy group at the 5-position of the tetrahydronaphthalene ring was shown to impart a certain 2 / 1 selectivity [5, 11] . The alkyl-chain length was modified and all of the compounds synthesized had good 2 receptor affinity, confirming the cyclohexylpiperazine as an important feature for 2 receptor binding in this series [5] . Thus, we retained the cyclohexylpiperazine moiety, and the propylnaphthalenic portion was either eliminated, or reduced in size ( Table 1 ). The results suggested that both basic nitrogen atoms are important (see amides 23 and 26), and that a lipophilic substituent was preferred at the N4 nitrogen atom of the piperazine ring in addition to the cyclohexyl ring at the N1 nitrogen atom (see 25 and 27, Table 1 ). This was supported by carbazole derivative (22) that displayed good 2 receptor affinity ( Table 1 ) and excellent (274-fold) selectivity [11] . The combined results suggested that efforts to predict the affinities of cyclohexylpiperazine derivatives should be considered since this class of compounds represents an optimal compromise between high affinity and selectivity for 2 receptor binding. Furthermore, several molecules belonging to this class have been shown to act as 2 receptor agonists (with important therapeutic potential) and some are a Data from [5] . b Data from [11] . c Data from [29] . d Data from [30] .
e Average values from [5] and [11] .
good candidates for the imaging of 2 receptors [5, 11] . Thus, we utilized the results obtained to computationally derive 2 -receptor 3D-QSAR models.
RESULTS AND DISCUSSION
With the purpose of forming a training set (TSET) from which our model was to be derived, the two enantiomers of PB28 (1) were re-analyzed ( Table 1) ; the enantiomers of shorter-chain derivatives (compounds 4, 10 and 11) were synthesized (Schemes 1 and 2) and affinity data were obtained. The results for the individual enantiomers of PB28, and the data obtained from the newly synthesized enantiomeric pairs, showed that the 2 receptor does not readily differentiate between the absolute configurations of this series of ligands. The same behavior has been previously demonstrated for other types of receptor ligands (e.g. piperidine analogs and -methylamines) [3, 6, 13] . The compounds used to build the CoMFA model as the training set (TSET), and those used to validate the model as a prediction set (PSET) ( Table 1) , were tested with the same protocols. Given the high structural resemblance, the same binding mode was assumed for the compounds belonging to both sets (TSET and PSET): this hypothesis is supported by the Hill slopes (n H ~ 1) obtained from the binding assays. Only one of the compounds used for the TSET did not bear a cyclohexyl ring (i.e. 1-acetyl-4-methylpiperazine; 27). Some of the compounds in the PSET were not resolved into their corresponding enantiomers. In these cases, the binding values obtained for the corresponding racemate was assigned to each of the enantiomers, since high similarity in the affinity values at the 2 receptors was generally displayed by the two enantiomers for several analogous compounds (1, 4, 10, 11 and 36); the eudismic ratio is never higher than 2.4 (1, PB28) for the resolved enantiomeric pairs.
FlexS Alignment-Based Model
The initial molecular alignments were performed using FlexS and compound ((-)-(R)-1) as a template because it showed the highest affinity of the compounds listed in Table  1 for 2 receptors, and also because its propylene linker is representative of many of the compounds in the study, facilitating the alignment. Models were built using both enantiomers as templates. The conformation of the template molecule(s) featured a doubly-protonated piperazine ring in the chair conformation, with the cyclohexyl substituent also in a chair conformation. The doubly-protonated state was selected because significant loss in affinity was observed when a) one of the piperazine nitrogen atoms is functionalized as an amide (see Table 1 and 35), or b) when the piperazine ring is substituted by a piperidine ring (studies in progress). The doubly-protonated state also makes the task of aligning the molecules less ambiguous since, in the case of monoprotonation, it is difficult to determine which of the two nitrogen atoms should be protonated [3] . The tetralin-1-yl-n-propyl substituent was modeled in a fully-extended conformation. Alignment of the analogs to the ((-)-(R)-1)-template is shown in Fig. (1a) . One of the compounds, ((-)-(R)-4), is aligned "backwards", such that its tetralin moiety is coincident with the cyclohexyl moiety of the template. We initially considered the possibility that the binding mode could be reversed in these roughly-symmetrical molecules, in accordance with pharmacophore models already proposed by Glennon and co-workers for 1 and 2 receptors [1] [2] [3] . In the FlexS alignment, except for ((-)-(R)-4), the methoxy and hydroxy groups tended to be clustered in a relatively small region of space. A model in which the orientation of ((-)-(R)-4) matched the other compounds did not show an improvement in overall statistical performance (data not shown).
The most statistically significant model using the FlexS alignment is depicted in Fig. (2a, b) , and the associated correlation scatter plot is shown in Fig. (3) . This model produced reasonably good statistics for the TSET (r 2 = 0.98, q 2 = 0.69 with 4 components, F = 273, standard error = 0.17). Several of the contours visible in the CoMFA map can be explained by the presence of TSET compounds in different regions of the 3D map. Two of the black wireframe patches, representing regions where a negative charge is favored, that surround the cyclohexyl ring coincide with the methoxytetralin moiety of ((-)-(R)-4). Other contours surrounding the cyclohexyl group probably arise as a result of the imperfect alignment of the cyclohexyl groups of the remaining training set members. The large white wireframe contour, where positive charge is favored, on the opposite side of the piperazine ring can be linked to the presence of a) the partially negatively-charged amide carbonyl oxygen atom of low-affinity compounds (23) and (26), and b) the partially positively-charged hydrogen atoms of the alkyl linker and the tetralin or cyclohexyl ring of the high-affinity compounds. The thin solid black contour (where steric bulk is favored) within the white wireframe region is present because the higher-affinity compounds tend to place steric bulk in this region. The large black wireframe contour on the left (Fig. 2a) or right ( Fig. 2b) side of the map likely arises from high-affinity methoxy-and hydroxy-containing compounds that tended to place the electronegative oxygen atoms of these functional groups in that region. The small solid black patch nested within this large black wireframe contour derives from the position of the methyl group of the methoxy substituent in compound (15) and both isomers of the lead compound PB28 (1). Finally, the solid gray contours flanking the tetralin moiety represent regions where steric bulk is detrimental to affinity; these regions coincide with the position of the lower-affinity naphthyl and carbazole compounds (20) , (21) and (22) that tend to place hydrophobic bulk there.
As expected, for the compounds in the PSET, the pK i values were much more poorly predicted than those of the TSET (PSET r 2 = 0.13). The predictions were more accurate for the R-enantiomers of compounds containing a 3-methylene chain-linker than for their corresponding S-isomers. However, the model failed to generalize, and many PSET compounds (even ones very similar to TSET compounds) were not predicted to within 0.5 log units. The poor pK i prediction of ((R)-35) can be ascribed to the inconsistent alignment of the piperizinamide-containing compounds in the TSET. This resulted in a lack of contour(s) needed for the proper prediction of a lower pK i for these compounds.
Since the compounds of the TSET were aligned to the (R) enantiomer of PB28 (1), we hypothesized a better match between the template and the (R) isomers of the molecules aligned to it than for the S isomers. We then generated an analogous FlexS alignment using the S-enantiomer of PB28 (1) as the template. The resulting CoMFA model, however, did not result in better predictions for the S isomers as we had expected.
The FlexS-generated alignment used for the model described above was obtained using the top-scoring aligned conformation of each compound as determined by the scoring function within FlexS. As such, the algorithm attempts to align all of the pharmacophoric elements within a set of compounds, whether or not they actually contribute to the binding of the compound to the receptor. We hypothesized that such an alignment of unimportant functionalities might result in the misalignment of the regions of the molecule that contribute to binding. We therefore constructed another set of aligned compounds in which the importance of the methoxy and hydroxyl groups was de-emphasized. Conformations for this alignment were selected rationally from the five top-ranked FlexS solutions. Although we did obtain a CoMFA model with improved TSET statistics, the PSET predictions were poorer than in the initial model. We thus decided to forego the use of the automated alignment algorithm and manually align the molecules so that we could obtain an alignment that would more closely match the pharmacophore suggested by the SAFIR.
Manual Alignment-Based Model
Compound 14 was selected as the template to facilitate the alignment process because a) the '1-naphthyl' substituent represents an "average" position between the (R)-and (S)-isomers of the 1,2,3,4-tetrahydronaphthalene (i.e. tetralin) structures, b) the unsubstituted naphthyl group represents a core substructure found in both substituted and unsubstituted naphthyl analogs and c) its propylene linker is the most commonly found among the set of compounds. The resulting alignment is shown in Fig. (1b) . All of the energy-minimized molecules were aligned using a rigid superimposition of the piperazine ring. This produced a nearly perfect alignment of the cyclohexylpiperazine (and methylpiperazine in 27) moieties. We also aligned the cyclic portion of the N4 substituent so as to maximize the overlap of the lipophilic ring structures with the naphthyl ring of (14) . This resulted in a few of the longer-length substituents adopting a "folded-over" conformation in which an N4 substituent ring face was situated near a portion of the alkyl linker. In contrast to the FlexS alignment, the methoxy and hydroxy substituents were not clustered together since (as shown in Fig. 1b) no attempt was made to superimpose them. This might be a more reliable/realistic superimposition because the specific location of these substituents has been shown to have minimal (if any) impact on affinity (e.g. compare affinities of isomers of 15, 18, and 19).
The most statistically significant model using our manual alignment is depicted in Fig. (2c, d) , and the correlation plot is shown in Fig. (4) . This model resulted in a weaker r 2 , F value and standard error, but the q 2 was improved (r 2 = 0.95, q 2 = 0.73 with 4 components, F = 87, standard error = 0.29), indicating superior predictivity. Interestingly, the weaker r 2 , F and standard error (compared to the best FlexS model) are attributable to the presence of a single outlier corresponding to the template compound (14) (Fig. 4) . The poor prediction stems from the fact that all of the other substituted naphthylpropyl compounds (with relatively low affinity) are nearly perfectly superimposed onto (14) , and the number and close proximity of these lower-affinity compounds will tend to lower the predicted pK i for (14) to a value closer to their average pK i value. In other words, since many of the compounds occupying the same region of space have relatively low pK i values, 14 were also assigned a low pK i value.
The contours of the CoMFA map correspond to observed SAFIR. The two solid gray contours arranged symmetrically about the naphthyl group correspond to the positions of substituents on the low-affinity naphthylpropyl-(18, 20 and 21), and tetralin-containing ((+)-(S)-4 and (+)-(S)-11), compounds. The larger white wireframe region results from the consistent alignment and close proximity of the carbonyl oxygen atom in the low-affinity amide-containing compound (27) . Like the FlexS alignment, the solid black contour is a result of the consistent placement of steric bulk in that region for the highest-affinity compounds. The two small symmetric black wireframe contours flanking the equatorial N4 nitrogen substituent are probably generated because the nearly electronically-neutral N4 equatorial substituents in the higher-affinity compounds are replaced by a hydrogen atom carrying a large partial positive charge in the low-affinity compound (25) . The two large black wireframe contours above the naphthalene ring in the template compound come primarily from the position of the methoxy group and aromatic carbons of the highest-affinity compound ((-)-(R)-1) and from the nitrogen atom of the carbazole ring in (22) . The large black wireframe region below the naphthyl ring arises as a result of the position of the partially negatively charged -cloud in the aromatic ring of (17), approximated by aromatic naphthalenic carbon atoms carrying a small partial negative charge.
The affinity of the PSET compounds were generally predicted much more accurately than in the FlexS-aligned model, as shown in Fig. (4) (PSET r 2 = 0.55). All of the predicted values were within 0.6 log units, with the exception of ((R)-32), ((S)-35), ((R)-36) and ((S)-36) and (37). In contrast to the FlexS model, both enantiomers were assigned pK i values close to the observed racemate pK i values. Good predictions were obtained independently from the presence and/or position of methoxy/hydroxy substituents, consistent with the observation that these groups do not significantly affect binding affinity. The best predictions were obtained for compounds that are similar to those used in the TSET. This includes compound (38), where the propylene linker is replaced with an ethoxy group. The most dissimilar compounds, ((+)-(R)-36), ((-)-(S)-36 ) and (37), contain an amide in the linker, but the position of the amide is different than in the amide-containing TSET compounds. This results in poor predictions for these compounds, likely in part because the aromatic ring system is marginally contained within the boundaries of the CoMFA map. Removal of these dissimilar compounds from the PSET (the "modified PSET") resulted in an increase in the r 2 value from 0.55 to 0.73 for the manual model, but had essentially no effect when the FlexS model was used (modified PSET r 2 = 0.16) (Fig. 3) . The affinities of compounds with varying alkyl-linker lengths were, generally, well predicted, with the poorest prediction being for ((R)-32). Multiple attempts to realign outliers did not yield better results. We found that a manual alignment of the compounds, while being rationally guided by the information extracted from the SAFIR, was able to produce a CoMFA model that showed superior predictive ability compared to that obtained when using naïve automated alignment algorithms. The 3D arrangement of the contours in the CoMFA map is consistent with an extended hydrophobic binding pocket bounded by regions of steric intolerance and polar interaction for the N4 substituent (vide supra). There was no appreciable contribution at the N1 position since, except for 1-acetyl-4-methylpiperazine (27) , all of the compounds were substituted by a cyclohexyl group at N1. Thus, there were no systematic changes in the fields at the N1 position that could be correlated with changes in the observed pK i values. This was reflected in the absence of contours about the N1-cyclohexyl substituent. In addition, we know from previous studies that smaller alkyl groups or the absence of an N1-substituent lead to a reduction in observed 2 binding affinity [4, 12] . Similarly, experimental evidence has shown that aromatic substituents larger than cyclohexyl at the N1 position are also detrimental to 2 binding affinity [12] . Overall, the model is qualitatively similar to that proposed for 1 ligands (i.e., an amine site flanked by primary and secondary hydrophobic regions) derived using deconstruction-reconstruction-elaboration methodology [2] and whose characteristics are, in part, correspondent to the generic binding characteristics proposed for 2 receptor ligands [3] . The SAFIR of the cyclohexylpiperazine compounds, a refinement of the basic 2 pharmacophore put forth in reference [3] , is summarized in Fig. (5) .
One other 3D-QSAR model from the literature [14] describing 2 -binding was generated using alignmentindependent GRIND descriptors [15] with -tropanyl derivatives, whose structures resemble the 2 antagonist SM-21 (3 -tropanyl-2-(4-chlorophenoxy)butyrate), and whose binding affinities are much lower than the agonist compounds described herein. Thus, a direct comparison of these models would appear to be inappropriate.
It should be noted that although the dibasic piperazines were modeled with both nitrogen atoms protonated, this does not imply that the ring must be a di-cation, though this has been suggested [16] by modeling the potential interactions of PB28 with nucleosome histone subunits. At this early stage, we don't know the amino acids that define the binding site (or indeed the receptor amino acid sequence itself), so we cannot specify which receptor atoms interact with the piperazine nitrogens, and thus their protonation states when bound to the receptor. CoMFA, the 3-D QSAR methodology employed here, is designed to correlate changes in stereoelectronic structure with corresponding observed changes in binding affinity. All of the dibasic piperazines were treated as di-cations so that the CoMFA model would not discriminate among these compounds based on the formal charge of the ring. It is quite possible that CoMFA models built using an unprotonated (or partially protonated) piperazine ring could give similarly predictive results, but the di-cationic state was employed here simply for convenience and to differentiate the H-bonding capability of the dibasic amine-containing compounds from their amide derivatives. Although we have found good predictivity using the manual alignment model shown here, this model is representative only of a particular chemical class (i.e., N1-cyclohexylpiperazines) and, as such, cannot be expected to accurately predict the affinity of 2 ligands in general. In addition, the 2 receptor has not yet been cloned, and information about the structure of the receptor site must be completely inferred from the structures of the ligands that bind to the receptor. This is complicated by the possibility that there may be multiple binding modes and/or sites at multiple subtypes [3] . Finally, we must acknowledge the limitations of CoMFA and the statistical methods used in general. It has been noted that the predictive power of a model, as measured by the q 2 statistic, can be misleading [17, 18] and that a high q 2 value does not guarantee that the model will be able to generalize. As a rule, compounds that are dissimilar to those in the TSET might not be reliably predicted with a high degree of accuracy, and great care must be used when selecting the compounds of the PSET [19] . Interestingly, and perhaps expectedly, we have been able to produce a more predictive model whose development was guided by chemical intuition rather than a blind reliance on mathematical and statistical methods, as suggested by Johnson [20] .
CONCLUSIONS
The observation that 1-cyclohexyl-4-[(naphthalene-1-yl)alkyl]piperazine derivatives generally display a good pharmacological profile for 2 receptors prompted us to construct a CoMFA model that could potentially predict the affinity of other cyclohexylpiperazine derivatives. To accomplish this goal, we synthesized three pairs of enantiomers, analogs of the lead-compound PB28 (1). Smaller cyclohexylpiperazine derivatives were also synthesized to investigate the importance of the naphthalene ring. Different CoMFA models were generated from alignments obtained with different algorithms. The most statistically significant model among those generated was obtained by a manual alignment of the analogs in which experimentallydetermined affinity data were taken into account. Reasonably good predictions were obtained for many of the compounds, and many of the observed structure-affinity relationships could be explained by the presence of steric and/or electrostatic contours in the CoMFA maps. Due to the inherent symmetry of the ligands, multiple binding modes are likely [3] . Cyclohexylpiperazines have been confirmed as good candidates for binding at 2 receptors with high affinity and they serve as an important tool to pharmacologically and functionally characterize the enigmatic 2 receptor. The present investigation further refines findings already reported [3] .
EXPERIMENTAL SECTION Chemistry
The synthesis of compounds (R)-and (S)- (4), (10) and (11) and of compounds (12) and (13) (4), respectively (Scheme 1). Carboxylic acid (5) [22] , upon transformation to the corresponding ketene, was allowed to react with (R)-or (S)-pantolactone, according to a previously reported synthesis [23] . The corresponding esterslactones, obtained with high diastereoselection (>95%), were reduced with LiAlH 4 to the corresponding alcohols and then transformed to the mesylate intermediates (+)-(R)-and (-)-(S)-(8) and [21] , which were then allowed to react with 1-cyclohexylpiperazine to lead, respectively, to compounds (-)-(R)-and (+)-(S)-(10) (Scheme 2). The enantiomers of the 5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl ethanoic acid (-)-(R)-and (+)-(S)-6 were obtained as previously reported [10] . They were reduced with LiAlH 4 to the corresponding alcohols (-)-(R)-and (+)-(S)- (7), which were subsequently reacted with mesyl chloride to afford respectively the mesyl derivative (-)-(R)-and (+)-(S)- (9) . Nucleophilic substitution of these latter with N-cyclohexylpiperazine afforded compounds (-)-(R)-and (+)-(S)-(11) (Scheme 2). Compounds (12) and (13) were obtained through substitution of 1-cyclohexylpiperazine with either iodoethane or 3-(cyclohexyl) propyl methanesulfonate (Scheme 2). The latter was obtained by mesylation of the commercially available 3-cyclohexyl-1-propanol. For all the enantiomeric final compounds, and some key intermediates, enantiomeric purity was analyzed by HPLC using Daicel Chiralcel OD. The conditions of elution will be reported for each compound. All targets were converted to the hydrochloride or dihydrochloride salts with gaseous HCl. The mp and [ ] D for the final compounds were determined on their salts.
Chemical Methods
Column chromatography was performed with 1:30 ICN silica gel 60 Å (63-200 m or 15-40 m) as the stationary phase. Melting points were determined in open capillaries on a Gallenkamp electrothermal apparatus. Elemental analyses of hydrochloride salts (C, H, N) were performed on a Eurovector Euro EA 3000 analyzer; the analytical results were within ±0.4% of the theoretical values for the formula given unless otherwise stated.
1 H NMR spectra were recorded at 300 MHz on a Mercury Varian spectrometer using CDCl 3 as solvent. The chemical shift values are reported in ppm ( ). Recording of mass spectra was done on an Agilent 6890-5973 MSD gas chromatograph/mass spectrometer; only significant m/z peaks, with their percentage of relative intensity in parentheses, are reported. Optical rotations were measured with a Perkin-Elmer 341 polarimeter at room temperature (20 ºC); concentrations are expressed as g/mL. HPLC was performed on a Waters chromatograph (Waters Assoc., Milford, MA) Model 600 equipped with a U6K model injector and a 481 model variable wavelength detector. Chemicals were purchased from Aldrich and Across, and were used without any further purification. After cooling to room temperature, the mixture was filtered and the filtrate was concentrated under reduced pressure. A solution of NaOH (3%, 10 mL) was added to the crude material, and the whole was extracted with CH 2 Cl 2 (3 15 mL). The organic phases were collected and dried (Na 2 SO 4 ), and solvent was removed under reduced pressure, affording a crude mixture which was purified by column chromatography with, first, CH 2 (3) (0.96 mmol, 0.24 g) in anhydrous toluene (15 mL) was added to cyclohexanone (1.90 mmol, 0.19 g) in the presence of 0.05 mL CF 3 COOH. The mixture was heated at reflux with a DeanStark device for 24 h. After cooling the reaction mixture, the solvent was removed by evaporation under vacuum and the residue was dissolved in absolute EtOH (10 mL). This solution was added in a dropwise manner to a NaBH 4 suspension (1.90 mmol, 0.07 g) in absolute EtOH (5 mL) at 0 ºC. The mixture was allowed to stir for 2 h at room temperature, and then quenched with H 2 O. The solvent was evaporated under reduced pressure and the residue was dissolved in H 2 O (15 mL) and extracted with CH 2 Cl 2 (3 15 mL). The organic portion was dried (Na 2 SO 4 ) and concentrated, and the crude material was purified by column chromatography using CH 2 General procedure to prepare (12) and (13): Cyclohexylpiperazine (3.14 mmol, 0.53 g) and Na 2 CO 3 (2.62 mmol, 0.27 g) were added to a solution of 3-(cyclohexyl) propan-1-yl methanesulfonate or iodoethane (2.62 mmol) in CH 3 CN (15 mL). The reaction mixture was heated at reflux overnight and, after cooling, the solvent was evaporated under reduced pressure to give a residue that was dissolved in H 2 O (15 mL) and extracted with CH 2 Cl 2 (3 15 mL). The organic portion was dried (Na 2 SO 4 ) and evaporated under reduced pressure to afford a crude oil which was purified by column chromatography with CH 2 Cl 2 and MeOH (9:1) as eluent affording the title compound as an oil in a 99% yield. 
1-Cyclohexyl-4-[3-(cyclohexyl

Receptor Binding Studies
The newly synthesized and/or analyzed target compounds as their hydrochloride (23, 26, 27) or dihydrochloride (1, 4, 10, 11-13, 23-26) salts were evaluated for in vitro affinity for 2 receptors by radioligand binding assays. All the procedures for the binding assays have been previously described. The 2 receptor binding determinations were performed according to a literature procedure [25] . The radioligand employed was tritiated di-o-tolylguanidine ([ 3 H]DTG) in the presence of 1 M (+)-pentazocine to mask 1 receptors, and rat liver membranes were used as the tissue source. [ 3 H]-DTG was purchased from Perkin-Elmer Life Sciences (Zavantem, Belgium). (+)-Pentazocine was obtained from Sigma-Aldrich-RBI s.r.l. (Milan, Italy). Wistar Hannover rats (250-300 g) were purchased from Harlan Laboratories, Italy. Specific binding was determined with cold DTG (87-95%). Concentrations required to inhibit 50% of radioligandspecific binding (IC 50 ) were determined using six to nine different concentrations of drug studied in two to three separate experiments with samples in duplicate. Scatchard parameters (K d and B max ), and apparent inhibition constants (K i ), were determined by nonlinear curve-fitting, using Prism, version 3.0 (GraphPad) [26] .
Modeling of PB28 (1) Analogs
All modeling, with the exception of the FlexS alignment, was performed using a SYBYL molecular modeling package [27] . Each structure was initially sketched and energyminimized using the Tripos Force Field (TFF) with Gasteiger-Hückel charges, with an implicit distance-dependent dielectric constant = 4.0 and was terminated when the energy gradient fell below 0.05 kcal/mol Å. The structures were modeled as either mono-or di-cations, depending on whether the molecule contained one or two basic nitrogen atoms.
Molecular alignments were performed using two different methods. FlexS-based alignments were performed using FlexS v.1.20.3 [28] with a fully-extended conformation for ((-)-(R)-1) serving as the template. FlexS uses an automatic incremental-construction algorithm that divides a ligand into small fragments, aligns a core fragment onto a template ligand conformation, then incrementally grows the remaining fragments, adjusting the conformation of the ligand to match the template molecule as closely as possible. The top-scoring solution for each ligand was selected for the CoMFA model. Manual alignments were also performed using an extended ((-)-(R)-1) template. First, the heavy atoms of the piperazine rings of each molecule were aligned using a rigid-body fit procedure. Then, the conformation of the R 1 group (see Table 1 ) was manually adjusted to identify low-energy conformations that resulted in a significant overlap of hydrophobic and/or polar regions of the 'test' ligand and either the PB28 template or one of the previously aligned ligands. This procedure was followed by energy-minimization using the TFF as described above.
After compounds were aligned, they were assigned AM1 charges (without geometry optimization) using the MOPAC interface within SYBYL. The appropriate formal charges were specified, and the MMOK keyword was included for amide-containing compounds. Finally, CoMFA models were derived from the aligned, charged sets of ligands. Unless otherwise noted, default parameters were used in the CoMFA 3D-QSAR procedure.
